Faculty, UW School of Medicine and Public Health

Mark Reichelderfer, MD

  • Gastroenterology and Hepatology
Mark Reichelderfer, MD

About

Mark Reichelderfer, MD is a member of the Inflammatory Bowel Disease Clinic and sees general GI patients for consultation and gastrointestinal procedures. He also provides services through our Liver and Pancreas program.

Languages spoken
  • English
University affiliation
  • Department of Medicine

Practice locations

  • Digestive Health CenterGastroenterology and Hepatology Clinic
    • 750 University Row / Madison, WI
    • (608) 890-5000
    • Closed now
    • View hours, services and more
  • Digestive Health CenterInterdisciplinary Inflammatory Bowel Disease Clinic
    • 750 University Row / Madison, WI
    • (608) 890-5000
    • Closed now
    • View hours, services and more

Education & credentials

Board certifications
  • Internal Medicine
  • Gastroenterology
Medical School
  • Columbia University College of Physicians and Surgeons, New York, NY
Fellowships
  • University of Wisconsin Hospital and Clinics, Madison, WI
Residencies
  • Mary Imogene Bassett Hospital and Clinics, Cooperstown, NY
Internships
  • Mary Imogene Bassett Hospital and Clinics, Cooperstown, NY

Specialties

Additional conditions and treatments
  • Abdominal Pain
  • Barrett's Esophagus
  • Celiac Disease
  • Colonoscopy
  • Double Balloon Enteroscopy
  • Endoscopic Mucosal Resection
  • Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Endoscopic Ultrasound
  • Enteral Stenting
  • Enterra™ Therapy Gastric Pacemaker
  • Gastroesophageal Reflux Disease
  • HALO Radiofrequency Ablation (RFA)
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
  • Malabsorption
  • Pancreatitis
  • Photodynamic Therapy
  • Upper Gastrointestinal Endoscopy

Research and publications

Dr. Reichelderfer's research interests include improvement in diagnostic imaging and therapy for inflammatory bowel disease, colon cancer screening in average-risk and high-risk populations, improved genetic screening for colon and other GI cancer in at-risk families, nutrition and celiac sprue.